熱門資訊> 正文
Elanco批准FDA紧急批准新的世界螺旋虫药物
2026-08-07 21:49
- The U.S. Food and Drug Administration has granted an emergency use authorization for Elanco Animal Health’s (ELAN) antiparasitic therapy CLiK Extra as a treatment to prevent new world screwworm infestations.
- The authorization came after the Department of Agriculture detected the first U.S. animal case of NWS in June in Texas amid an ongoing outbreak of the parasitic infestation in Central American countries and Mexico.
- The EUA permits the sale of CLiK Extra over the counter as a wound spray for topical use in sheep, cattle, goats, swine, and camels, as well as captive and captured wild animals such as deer and American bison, the FDA said.
- “Today's emergency use authorization provides a new tool for preventing the spread of New World screwworm infestations, and we will continue to work to combat this threatening pest,” added the acting FDA Commissioner Kyle Diamantas.
More on Elanco
- Elanco Animal Health Incorporated 2026 Q2 - Results - Earnings Call Presentation
- Elanco Animal Health Incorporated (ELAN) Q2 2026 Earnings Call Transcript
- Elanco Animal Health Incorporated (ELAN) Presents At 46th Annual William Blair Growth Stock Conference Transcript
- Elanco anticipates 6%-7% organic constant currency growth and ~$3x net leverage by year-end 2026
- Elanco posts Q2 beat as Zenrelia hits blockbuster status
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
